INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,332,773 | $27,828,000 | 5.75% |
| First Light Asset Management, LLC | 2,036,645 | $42,525,000 | 2.82% |
| Altium Capital Management LP | 141,856 | $2,962,000 | 0.82% |
| PURA VIDA INVESTMENTS, LLC | 909,660 | $18,994,000 | 0.54% |
| Rock Springs Capital Management LP | 1,080,200 | $22,555,000 | 0.49% |
| Novo Holdings A/S | 508,922 | $10,626,000 | 0.44% |
| Davide Leone & Partners Investment Co Ltd. | 109,240 | $2,281,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 256,800 | $5,362,000 | 0.15% |
| Bellevue Group AG | 617,968 | $12,903,000 | 0.14% |
| Gyon Technologies Capital Management, LP | 13,318 | $278,000 | 0.12% |